The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nakao, N., Yoshimura, A., Morita, H., Takada, M., Kayano, T., & Ideura, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12229-5 · Cited by 970
RetractedLevey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Self-citationSarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Self-citationTelmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Epstein, F. H., Brenner, B. M., Meyer, T. W., & Hostetter, T. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209093071104 · Cited by 2,075
Self-citationTurner, R. D., & Holman, R. R. (1998) · Cited by 1,974
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Surrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Mann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Hillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551
Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516
Self-citationPrincipal Stratification in Causal Inference
Frangakis, C. E., & Rubin, D. B. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00021.x · Cited by 1,511
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,342
(2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.003 · Cited by 1,245
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C., Kim, M. Y., Buyon, J., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,128
Jafar, T. H., Schmid, C. H., Landa, M., Giatras, I., Toto, R., Remuzzi, G., Maschio, G., Brenner, B. M., Kamper, A., Zucchelli, P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-2-200107170-00007 · Cited by 1,092
Self-citationPodocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., Garrido, E. D. R., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10461 · Cited by 1,077
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes · doi:10.2337/db05-1620 · Cited by 927
Ruggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910
Properties of the Glomerular Barrier and Mechanisms of Proteinuria
Haraldsson, B., Nyström, J., & Deen, W. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00055.2006 · Cited by 909
Boumpas, D. T., Austin, H. A., Balow, J. E., Vaughan, E. M., Yarboro, C. H., Klippel, J. H., & Steinberg, A. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)92292-n · Cited by 823
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
Modification of Diet in Renal Disease Study Group, Hunsicker, L. G., Adler, S., Caggiula, A., England, B. K., Greene, T., Kusek, J. W., Rogers, N. L., Teschan, P. E., & Beck, G. (1997) · Kidney International · doi:10.1038/ki.1997.260 · Cited by 702
Ruggenenti, P., Perna, A., Loriga, G., Ganeva, M., Ene-Iordache, B., Turturro, M., Lesti, M., Perticucci, E., Chakarski, I. N., Leonardis, D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71082-5 · Cited by 644
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
Remuzzi, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27699 · Cited by 618
Corticosteroids in IgA nephropathy: a randomised controlled trial
Pozzi, C., Bolasco, P., Fogazzi, G., Andrulli, S., Altieri, P., Ponticelli, C., & Locatelli, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03563-6 · Cited by 532
Eknoyan, G., Hostetter, T., Bakris, G. L., Hebert, L., Levey, A. S., Parving, H.-H., Steffes, M. W., & Toto, R. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00826-6 · Cited by 506
Self-citationChan, T.-M., Tse, K.-C., Tang, C. S.-O., Mok, M.-Y., & Li, F.-K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080686 · Cited by 479
Nelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 477
Valmadrid, C. T., Klein, R., Moss, S. E., & Klein, B. E. K. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1093 · Cited by 472
Diseases of the kidney and urinary tract
Schrier, R. W. (2001) · Cited by 396
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20666 · Cited by 391
Current issues in measurement and reporting of urinary albumin excretion
Miller, W. G., Bruns, D. E., Hortin, G. L., Sandberg, S., Aakre, K. M., McQueen, M. J., Itoh, Y., Lieske, J. C., Seccombe, D. W., Jones, G., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.106567 · Cited by 381
Self-citationMicroalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080872 · Cited by 370
Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
Cattran, D. C., Appel, G. B., Hebert, L. A., Hunsicker, L. G., Pohl, M. A., Hoy, W. E., Maxwell, D. R., Kunis, C. L., & Syndrome, F. T. N. A. N. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041484.x · Cited by 367
Self-citationPredicting progression in IgA nephropathy
Bartosik, L. P., Lajoie, G., Sugar, L., & Cattran, D. C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27689 · Cited by 363
Self-citationTreatment of IgA Nephropathy with ACE Inhibitors: A Randomized and Controlled Trial
Praga, M., Gutiérrez, E., González, E., Morales, E., & Hernández, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068460.37369.dc · Cited by 345
The Number, Quality, and Coverage of Randomized Controlled Trials in Nephrology
Strippoli, G. F. M., Craig, J. C., & Schena, F. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000100125.21491.46 · Cited by 343
Rahman, M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.936 · Cited by 340
Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?
Temple, R. (1999) · JAMA · doi:10.1001/jama.282.8.790 · Cited by 337
Messent, J. W. C., Elliott, T. G., Hill, R. D., Jarrett, R. J., Keen, H., & Viberti, G. (1992) · Kidney International · doi:10.1038/ki.1992.128 · Cited by 328
Cattran, D. C., Appel, G. B., Hebert, L. A., Hunsicker, L. G., Pohl, M. A., Hoy, W. E., Maxwell, D. R., & Kunis, C. L. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00778.x · Cited by 326
Self-citationWarram, J. H., Gearin, G., Laffel, L., & Krolewski, A. S. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v76930 · Cited by 313
Value of a Complete or Partial Remission in Severe Lupus Nephritis
Chen, Y. E., Korbet, S. M., Katz, R. S., Schwartz, M. M., & Lewis, E. J. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03280807 · Cited by 312
Lea, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.947 · Cited by 297
Discovery of Protein Biomarkers for Renal Diseases
Hewitt, S. M., Dear, J., & Star, R. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129114.92265.32 · Cited by 295
Focal and Segmental Glomerulosclerosis: Definition and Relevance of a Partial Remission
Troyanov, S., Wall, C. A., Miller, J. A., Scholey, J. W., & Cattran, D. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070593 · Cited by 282
Self-citationTacrolimus monotherapy in membranous nephropathy: A randomized controlled trial
Praga, M., For the GRUPO ESPAÑOL DE ESTUDIO DE LA NEFROPATÍA MEMBRANOSA (Members of the Group listed at the end of the paper), Barrio, V., Juárez, G. F., & Luño, J. (2007) · Kidney International · doi:10.1038/sj.ki.5002215 · Cited by 280
Idiopathic membranous nephropathy: Definition and relevance of a partial remission
Troyanov, S., Wall, C. A., Scholey, J. W., Miller, J. A., & Cattran, D. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00873.x · Cited by 257
Self-citationMiettinen, H., Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1996) · Stroke · doi:10.1161/01.str.27.11.2033 · Cited by 257
Toyoda, M., Najafian, B., Kim, Y., Caramori, M. L., & Mauer, M. (2007) · Diabetes · doi:10.2337/db07-0019 · Cited by 257
Grootscholten, C., Erythematosus, F. T. D. W. P. O. S. L., Ligtenberg, G., Hagen, E. C., van den Wall Bake, A. W. L., de Glas-Vos, J. W., Bijl, M., Assmann, K. J., Bruijn, J. A., Weening, J. J., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001630 · Cited by 237
Diseases of the kidney and urinary tract
Edelmann, C. M., & Bernstein, J. (1992) · Medical Entomology and Zoology · Cited by 232
Levey, A. S., Schoolwerth, A. C., Burrows, N. R., Williams, D. E., Stith, K. R., & McClellan, W. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.11.019 · Cited by 227
Self-citationRahman, M., Pressel, S., Davis, B. R., Nwachuku, C., Wright, J. T., Whelton, P. K., Barzilay, J., Batuman, V., Eckfeldt, J. H., Farber, M. A., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00005 · Cited by 227
Appel, G. B., Blum, C. B., Chien, S., Kunis, C. L., & Appel, A. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506133122404 · Cited by 219
Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives
de Jong, P. E., & Curhan, G. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010097 · Cited by 218
Long-term outcome in children and adults with classic focal segmental glomerulosclerosis
Cattran, D., & Rao, P. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9669427 · Cited by 212
Self-citationRole of Remission Clinics in the Longitudinal Treatment of CKD
Ruggenenti, P., Perticucci, E., Cravedi, P., Gambara, V., Costantini, M., Sharma, S. K., Perna, A., & Remuzzi, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007090970 · Cited by 204
Related Causal Frameworks for Surrogate Outcomes
Joffe, M. M., & Greene, T. (2009) · Biometrics · doi:10.1111/j.1541-0420.2008.01106.x · Cited by 203
The Natural Course of Microalbuminuria in Insulin‐dependent Diabetes: A 10‐year Prospective Study
Mathiesen, E. R., Rønn, B., Storm, B., Foght, H., & Deckert, T. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00528.x · Cited by 178
The long-term outcome of 93 patients with proliferative lupus nephritis
Moroni, G., Quaglini, S., Gallelli, B., Banfi, G., Messa, P., & Ponticelli, C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm245 · Cited by 173
Appel, L. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.832 · Cited by 167
Cellular responses to protein overload: key event in renal disease progression
Zoja, C., Benigni, A., & Remuzzi, G. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200401000-00005 · Cited by 148
Steroid Therapy during the Early Stage of Progressive IgA Nephropathy
Kobayashi, Y., Hiki, Y., Kokubo, T., Horii, A., & Tateno, S. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188848 · Cited by 148
Steroid Treatment for Severe Childhood IgA Nephropathy
Yoshikawa, N., Honda, M., Iijima, K., Awazu, M., Hattori, S., Nakanishi, K., & Ito, H. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01120905 · Cited by 143
Surrogate End Points for Clinical Trials of Kidney Disease Progression
Stevens, L. A., Greene, T., & Levey, A. S. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00600206 · Cited by 139
Self-citationHigher Levels of Albuminuria within the Normal Range Predict Incident Hypertension
Forman, J. P., Fisher, N. D. L., Schopick, E. L., & Curhan, G. C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010038 · Cited by 126
Atubular Glomeruli and Glomerulotubular Junction Abnormalities in Diabetic Nephropathy
Najafian, B., Kim, Y., Crosson, J. T., & Mauer, M. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000057854.32413.81 · Cited by 125
Ibsen, H., Olsen, M. H., Wachtell, K., Borch‐Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlöf, B., Snapinn, S. M., Wan, Y., & Lyle, P. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1724 · Cited by 117
Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.
Łapiński, R., Perico, N., Remuzzi, A., Sangalli, F., Benigni, A., & Remuzzi, G. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v75653 · Cited by 113
Nelson, R. G. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400090057011 · Cited by 109
Early prediction of IgA nephropathy progression: Proteinuria and AOPP are strong prognostic markers
Descamps‐Latscha, B., Witko‐Sarsat, V., Nguyen‐Khoa, T., Nguyen, A., Gausson, V., Mothu, N., Cardoso, C. C., Noël, L., Guérin, A. P., London, G. M., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00926.x · Cited by 105
Burzykowski, T., Molenberghs, G., & Buyse, M. E. (2003) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/j.1467-985x.2004.00293.x · Cited by 98
The COOPERATE trial: a letter of concern
Kunz, R., Wolbers, M., Glass, T. R., & Mann, J. F. E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60681-9 · Cited by 94
Mann, J. F. E., Gerstein, H. C., Yi, Q., Franke, J., Lonn, E., Hoogwerf, B. J., Rashkow, A. M., & Yusuf, S. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.015 · Cited by 85
Blood pressure as an example of a biomarker that functions as a surrogate
Desai, M. G., Stockbridge, N., & Temple, R. (2006) · The AAPS Journal · doi:10.1208/aapsj080117 · Cited by 75
Progression of overt nephropathy in non-insulin-dependent diabetes
Myers, B. D., Nelson, R. G., Tan, M., Beck, G. J., Bennett, P. H., Knowler, W. C., Blouch, K. L., & Mitch, W. E. (1995) · Kidney International · doi:10.1038/ki.1995.246 · Cited by 66
Abnormal Albuminuria as a Predictor of Mortality and Renal Impairment in Chinese Patients With NIDDM
Chan, J. C. N., Cheung, C., Cheung, M. Y. F., Swaminathan, R., Critchley, J., & Cockram, C. S. (1995) · Diabetes Care · doi:10.2337/diacare.18.7.1013 · Cited by 57
Chronic Kidney Disease and the Public Health: Gaps in Evidence From Interventional Trials
Himmelfarb, J. (2007) · JAMA · doi:10.1001/jama.297.23.2630 · Cited by 50
Pavkov, M. E., Knowler, W. C., Hanson, R. L., Bennett, P. H., & Nelson, R. G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.011 · Cited by 47
Nephrotic Syndrome in Diabetic Kidney Disease: An Evaluation and Update of the Definition
Stoycheff, N., Stevens, L. A., Schmid, C. H., Tighiouart, H., Lewis, J. B., Atkins, R. C., & Levey, A. S. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.016 · Cited by 46
Self-citationSurrogate End Points and FDA Approval
Psaty, B. M., & Lumley, T. (2008) · JAMA · doi:10.1001/jama.299.12.1474 · Cited by 43
Losartan in patients with type 2 diabetes and proteinuria: Observations from the RENAAL Study
Shahinfar, S., Dickson, T. Z., Ahmed, T., Zhang, Z., Ramjit, D. R., Smith, R. D., & Brenner, B. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.13.x · Cited by 33
Heerspink, H. J. L., Fowler, M. J., Volgi, J., Reutens, A. T., Klein, I., Herskovits, T., Packham, D., Fraser, I. R., Schwartz, S. L., Abaterusso, C., et al. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02249.x · Cited by 33
Pavkov, M. E., Mason, C. C., Bennett, P. H., Curtis, J. M., Knowler, W. C., & Nelson, R. G. (2009) · Diabetes Care · doi:10.2337/dc08-2325 · Cited by 26
Cystatin C and the Risk of Death
Berghout, A., Wulkan, R. W., & den Hollander, J. G. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051667 · Cited by 18
Which Antihypertensive Agents in Chronic Kidney Disease?
Levey, A. S., & Uhlig, K. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00011 · Cited by 16
Self-citation
Cited by
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Self-citationKDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
“Diabetic kidney disease was initially characterized as a disease manifesting as albuminuria followed by decrease in GFR.34-36 However, a number of studies demonstrated that impaired GFR can occur without substantial albuminuria and that DKD can manifest solely as impaired GFR.37-41 Our study suggests that the clinical…”
BackgroundInfluentialLevey, A. S., Inker, L. A., Matsushita, K., Greene, T., Willis, K., Lewis, E., de Zeeuw, D., Cheung, A. K., & Coresh, J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.030 · Cited by 620
Self-citation
Metadata
- Authors
- Levey, A. S., Cattran, D., Friedman, A., Miller, W. G., Sedor, J., Tuttle, K., Kasiske, B., & Hostetter, T.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 54
- Issue
- 2
- Pages
- 205-226
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W1983539151
- Cited by
- 298
- References
- 103
- FWCI
- 19.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.